Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3051% below fair value
$44.34+0.14 (+0.32%)
Close on Nov 13, 2026Market cap $64.26BP/E 18.8Yield –
Boston Scientific cash
Cash and short-term investments held at the end of each period.
Boston Scientific's cash was $609.00M at Sep 30, 2026. For fiscal 2025 it was $1.97B, up 224.3% from the year before. Over ten years it grew 17.3% a year on average. The highest annual figure on record is $2.17B in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.97B | +224.3% |
| FY2024 | Dec 31, 2024 | $606.00M | -29.9% |
| FY2023 | Dec 31, 2023 | $865.00M | -23.2% |
| FY2022 | Dec 31, 2022 | $1.13B | -48.1% |
| FY2021 | Dec 31, 2021 | $2.17B | +8.7% |
| FY2020 | Dec 31, 2020 | $2.00B | +228.7% |
| FY2019 | Dec 31, 2019 | $607.00M | -26.8% |
| FY2018 | Dec 31, 2018 | $829.00M | -18.5% |
| FY2017 | Dec 31, 2017 | $1.02B | +108.8% |
| FY2016 | Dec 31, 2016 | $487.00M | +21.8% |
| FY2015 | Dec 31, 2015 | $400.00M | -31.9% |
| FY2014 | Dec 31, 2014 | $587.00M | +170.5% |
| FY2013 | Dec 31, 2013 | $217.00M | +4.8% |
| FY2012 | Dec 31, 2012 | $207.00M | -22.5% |
| FY2011 | Dec 31, 2011 | $267.00M | +25.4% |
| FY2010 | Dec 31, 2010 | $213.00M | -75.3% |
| FY2009 | Dec 31, 2009 | $864.00M | -47.3% |
| FY2008 | Dec 31, 2008 | $1.64B | +13.0% |
| FY2007 | Dec 31, 2007 | $1.45B | -12.9% |
| FY2006 | Dec 31, 2006 | $1.67B | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $609.00M | -52.2% |
| Q2 FY2026 | Jun 30, 2026 | $539.00M | +0.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.45B | +100.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.97B | +224.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.28B | -49.0% |
| Q2 FY2025 | Jun 30, 2025 | $534.00M | -81.7% |
| Q1 FY2025 | Mar 31, 2025 | $725.00M | -68.9% |
| Q4 FY2024 | Dec 31, 2024 | $606.00M | -29.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.50B | +162.8% |
| Q2 FY2024 | Jun 30, 2024 | $2.91B | +583.8% |
| Q1 FY2024 | Mar 31, 2024 | $2.33B | +308.6% |
| Q4 FY2023 | Dec 31, 2023 | $865.00M | -23.2% |
| Q3 FY2023 | Sep 30, 2023 | $952.00M | +181.7% |
| Q2 FY2023 | Jun 30, 2023 | $426.00M | +54.3% |
| Q1 FY2023 | Mar 31, 2023 | $570.00M | +75.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.13B | -48.1% |
| Q3 FY2022 | Sep 30, 2022 | $338.00M | -82.6% |
| Q2 FY2022 | Jun 30, 2022 | $276.00M | -89.7% |
| Q1 FY2022 | Mar 31, 2022 | $325.00M | -83.9% |
| Q4 FY2021 | Dec 31, 2021 | $2.17B | +8.7% |
| Q3 FY2021 | Sep 30, 2021 | $1.95B | -3.7% |
| Q2 FY2021 | Jun 30, 2021 | $2.68B | +55.2% |
| Q1 FY2021 | Mar 31, 2021 | $2.02B | +444.9% |
| Q4 FY2020 | Dec 31, 2020 | $2.00B | +228.7% |
| Q3 FY2020 | Sep 30, 2020 | $2.02B | +630.0% |
| Q2 FY2020 | Jun 30, 2020 | $1.72B | +1301.6% |
| Q1 FY2020 | Mar 31, 2020 | $370.00M | +166.2% |
| Q4 FY2019 | Dec 31, 2019 | $607.00M | -26.8% |
| Q3 FY2019 | Sep 30, 2019 | $277.00M | +64.9% |
| Q2 FY2019 | Jun 30, 2019 | $123.00M | -40.9% |
| Q1 FY2019 | Mar 31, 2019 | $139.00M | -51.6% |
| Q4 FY2018 | Dec 31, 2018 | $829.00M | -18.5% |
| Q3 FY2018 | Sep 30, 2018 | $168.00M | -20.0% |
| Q2 FY2018 | Jun 30, 2018 | $208.00M | +6.7% |
| Q1 FY2018 | Mar 31, 2018 | $287.00M | +84.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.02B | +108.8% |
| Q3 FY2017 | Sep 30, 2017 | $210.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $195.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $156.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $487.00M | – |
See a number that looks wrong?